CD180

CD180 molecule, the group of CD molecules

Basic information

Region (hg38): 5:67179613-67196799

Previous symbols: [ "LY64" ]

Links

ENSG00000134061NCBI:4064OMIM:602226HGNC:6726Uniprot:Q99467AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CD180 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD180 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
clinvar
6
missense
43
clinvar
1
clinvar
1
clinvar
45
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 43 4 4

Variants in CD180

This is a list of pathogenic ClinVar variants found in the CD180 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-67182954-A-G not specified Uncertain significance (Jan 16, 2024)3140356
5-67183008-G-A not specified Uncertain significance (Jun 12, 2023)2559651
5-67183037-C-T Likely benign (Apr 04, 2018)725876
5-67183041-C-G not specified Uncertain significance (Sep 13, 2023)2591350
5-67183060-T-C not specified Uncertain significance (Jan 03, 2024)3140355
5-67183091-C-T Benign (Jun 04, 2018)709971
5-67183180-T-G not specified Uncertain significance (Jan 23, 2024)3140354
5-67183240-C-T not specified Likely benign (Jul 05, 2023)2603094
5-67183269-A-G not specified Uncertain significance (Oct 28, 2023)3140353
5-67183393-C-G not specified Uncertain significance (Apr 07, 2023)2534997
5-67183398-T-G not specified Uncertain significance (Oct 20, 2023)3140352
5-67183429-G-A not specified Uncertain significance (Feb 17, 2023)2471372
5-67183454-A-T not specified Uncertain significance (Jun 23, 2023)2605946
5-67183555-T-C Benign (Jun 12, 2018)787819
5-67183573-G-C not specified Uncertain significance (Dec 09, 2023)3140350
5-67183584-G-A not specified Uncertain significance (Aug 14, 2023)2598729
5-67183600-C-A not specified Uncertain significance (Mar 29, 2022)2280703
5-67183649-C-T Benign (May 29, 2018)782700
5-67183744-C-G not specified Uncertain significance (Apr 07, 2023)2510537
5-67183753-C-T not specified Uncertain significance (Nov 17, 2022)2389999
5-67183800-G-A not specified Uncertain significance (Jan 05, 2022)2270297
5-67183869-T-G not specified Uncertain significance (Oct 30, 2023)3140366
5-67183920-G-A not specified Uncertain significance (Jun 13, 2023)2560151
5-67183927-T-G not specified Uncertain significance (Sep 13, 2023)2623761
5-67184014-C-T not specified Uncertain significance (Feb 27, 2024)3140364

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CD180protein_codingprotein_codingENST00000256447 314525
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00006840.91612534124041257470.00162
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1943333430.9710.00001714416
Missense in Polyphen8792.8060.937441329
Synonymous-0.3031431381.030.000007401279
Loss of Function1.59915.80.5696.70e-7220

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001870.00187
Ashkenazi Jewish0.006470.00647
East Asian0.0002220.000217
Finnish0.001300.00129
European (Non-Finnish)0.001570.00156
Middle Eastern0.0002220.000217
South Asian0.002290.00219
Other0.0009810.000978

dbNSFP

Source: dbNSFP

Function
FUNCTION: May cooperate with MD-1 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) in B-cells. Leads to NF-kappa-B activation. Also involved in the life/death decision of B-cells (By similarity). {ECO:0000250}.;
Pathway
Regulation of toll-like receptor signaling pathway;Toll-Like Receptors Cascades;Innate Immune System;Immune System;Toll Like Receptor 4 (TLR4) Cascade (Consensus)

Recessive Scores

pRec
0.107

Intolerance Scores

loftool
0.645
rvis_EVS
0.07
rvis_percentile_EVS
59.11

Haploinsufficiency Scores

pHI
0.0612
hipred
N
hipred_score
0.112
ghis
0.490

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.769

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cd180
Phenotype
hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); renal/urinary system phenotype; immune system phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
B cell proliferation involved in immune response;inflammatory response;positive regulation of lipopolysaccharide-mediated signaling pathway;innate immune response;cellular response to lipopolysaccharide
Cellular component
extracellular space;plasma membrane;integral component of membrane;extracellular matrix
Molecular function
protein binding